Taiwan FDA registration 691a7eb906426eccf213df2e6138dc75

"Siemens" second generation alkaline phosphatase concentrate group

TW: “西門子”第二代鹼性磷酸酶濃縮試劑組
Taiwan flagTaiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.;; RANDOX LABORATORIES LTD.·Registered Apr 12, 2016 – Apr 12, 2026Expired
Registration details
Analysis ID
691a7eb906426eccf213df2e6138dc75
Customs Code
DHA05602832800
Company information
Manufacturer Country
United Kingdom;;United States
Authorized Representative
SIEMENS HEALTHCARE LIMITED
Product details
Intended Use
This product is used with an ADVIA Chemistry 1200, 1800, 2400, or XPT analyzer to quantitatively detect alkaline phosphatase in human serum or plasma.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1050 Alkaline phosphatase or isoenzyme testing system
Import Information
Contract manufacturing;; input
Dates and status
Registration Date
Apr 12, 2016
Expiry Date
Apr 12, 2026
About this record

Access comprehensive regulatory information for "Siemens" second generation alkaline phosphatase concentrate group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 691a7eb906426eccf213df2e6138dc75 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.;; RANDOX LABORATORIES LTD.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices